News

Professors Michelle Chui and Glen Kwon receive one of UW–Madison’s top faculty honors: Vilas Distinguished Achievement Professorships.

In the 2020–21 Fiscal Year, School of Pharmacy researchers received six patents to improve drug delivery and discovery.

Professor Glen Kwon receives a new grant from the National Institutes of Health for research targeting triple-negative breast cancer.

Researchers in the School of Pharmacy’s Kwon Lab have been awarded a patent for a promising new therapy with implications for many conditions, such as kidney disease, heart failure, and even COVID-19.

Soon after graduation, Tony Tam (PhD ’18) advances drug development and formulation at Merck.

Professors Seungpyo Hong, Sandro Mecozzi, Lingjun Li and Glen Kwon are combining their expertise to create a new research center that will improve the efficacy of new drug leads.

Research by Professor Glen Kwon and former graduate student Tony Tam (PhD ’18) is working toward enhancing the efficacy of chemotherapy.

The School’s Professor Weiping Tang is the principal investigator on the project that won funding from the UW2020: WARF Discovery Initiative program.

Two professors at the UW–Madison School of Pharmacy’s Pharmaceutical Sciences Division are up for the challenge of being both entrepreneurs and academic researchers, and they’re both targeting cancer.

Doctoral student Yu Tong (Tony) Tam at the University of Wisconsin–Madison School of Pharmacy has been honored with a graduate award from the American Association of Indian Pharmaceutical Scientists (AAiPS)

Pharmaceutical Sciences professor Glen Kwon and assistant professors, Jason Kwan and Jiaoyang Jiang are three of seven faculty who submitted applications for the annual Fall Research Competition and selected to receive funding in this round.

Glen Kwon, professor, in the Pharmaceutical Sciences Division, has received The American Association of Pharmaceutical Scientists (AAPS) Outstanding Manuscript Award for outstanding achievement in pharmaceutical technologies

Glen Kwon, professor, in the Pharmaceutical Sciences Division, co-founder and chief scientific officer of Co-D Therapeutics, a University of Wisconsin–Madison spinoff, is developing a three-drug cocktail to battle a wide range of cancers.

An article authored by Glen Kwon, professor, in the Pharmaceutical Sciences Division, along with Tony Tam, PhD graduate student, and Jieming Gao, post-doctoral researcher, both members of his lab, was published online